Terms: = Bone cancer AND PR, PGR, progesterone receptor AND Prognosis
195 results:
1. Outcomes of the patients with metastatic male breast cancer.
Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
[TBL] [Abstract] [Full Text] [Related]
2. Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population-based study.
Zhou X; Liu M; Zheng Z; Cao X; Lin Y; Xu Y; Li Y; Wang HC; Sun Q
Cancer; 2024 Apr; 130(S8):1464-1475. PubMed ID: 38198445
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
4. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast cancer with Focus on Triple-negative Breast cancer.
Naeimzadeh Y; Heidari Z; Razban V; Khajeh S
Curr Mol Pharmacol; 2024; 17(1):e18761429263841. PubMed ID: 37916633
[TBL] [Abstract] [Full Text] [Related]
5. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
Zhong X; Lin Y; Zhang W; Bi Q
Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
[TBL] [Abstract] [Full Text] [Related]
6. A multicenter retrospective analysis of clinical outcomes of intracranial chondrosarcoma in 26 patients.
Liu H; Li Z; Xue Y; Zhao T; Wu Y
Sci Rep; 2023 Sep; 13(1):14647. PubMed ID: 37669996
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
8. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract] [Full Text] [Related]
9. A Rare Case of Intraosseous Papillary Hemangioma of the Head and Neck.
Geetha SD; Abdelwahed M; Edelman MC; Buyuk A; Gordon D; Arvind R
Int J Surg Pathol; 2024 Apr; 32(2):418-421. PubMed ID: 37306145
[TBL] [Abstract] [Full Text] [Related]
10. An Immunohistochemical Study of Breast cancer Brain Metastases: The Role of CD44 and AKT in the prognosis.
Martins Gama J; Caetano Oliveira R; Teixeira P; Silva F; Abrantes C; Figueiredo P; Simões S; Rebelo O; Cipriano MA
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):318-323. PubMed ID: 37093706
[TBL] [Abstract] [Full Text] [Related]
11. TOR1B: a predictor of bone metastasis in breast cancer patients.
Nguyen MN; Akter S; Akhter H; Ansary S; Han S; Shin Y; Ha J; Kang I; Kim SS; Choi TG
Sci Rep; 2023 Jan; 13(1):1495. PubMed ID: 36707670
[TBL] [Abstract] [Full Text] [Related]
12. Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients.
Fu D
Clin Transl Oncol; 2023 Jun; 25(6):1710-1718. PubMed ID: 36640208
[TBL] [Abstract] [Full Text] [Related]
13. Risk stratification system and visualized dynamic nomogram constructed for predicting diagnosis and prognosis in rare male breast cancer patients with bone metastases.
Gao B; Ou XL; Li MF; Wang MD; Huang F
Front Endocrinol (Lausanne); 2022; 13():1013338. PubMed ID: 36440188
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases.
Lin M; Jin Y; Lv H; Hu X; Zhang J
Int J Cancer; 2023 Apr; 152(7):1476-1489. PubMed ID: 36408915
[TBL] [Abstract] [Full Text] [Related]
15. Surgical efficacy and survival prediction of patients with unspecified malignant bone tumors.
He S; Jiang R; Sun H; Yang J; Ye C; Liu W; Yang X; Cai X; Xiao J
BMC Cancer; 2022 Oct; 22(1):1078. PubMed ID: 36266614
[TBL] [Abstract] [Full Text] [Related]
16. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
[TBL] [Abstract] [Full Text] [Related]
17. Insulin resistance and racial disparities in breast cancer prognosis: a multi-center cohort study.
Gallagher EJ; Greco G; Lin S; Yagnik R; Feldman SM; Port E; Friedman NB; Boolbol SK; Killelea B; Pilewskie M; Choi L; LeRoith D; Bickell NA
Endocr Relat Cancer; 2022 Dec; 29(12):693-701. PubMed ID: 36197762
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic significance of different degrees of resection of skull base chordoma.
Wang Y; Peng Z; Wang Y; Fan R; Zhang H; Jiang W
Clin Transl Oncol; 2022 Dec; 24(12):2441-2452. PubMed ID: 35953670
[TBL] [Abstract] [Full Text] [Related]
19. De Novo mutation in Epidermal growth factor receptor (EGFR)-D761Y responding to third generation tyrosine kinase inhibitor Osimertinib: A case report.
Ding Y; Dong H; Li Y; Liu L; Cai Y; Wang Y; Tian S; Dai C
Medicine (Baltimore); 2022 Jul; 101(29):e29332. PubMed ID: 35866776
[TBL] [Abstract] [Full Text] [Related]
20. Case Report: Successful Immunotherapy Improved the prognosis of the Unfavorable Subset of cancer of Unknown Primary.
Mei J; Wang H; Fan H; Ding J; Xu J
Front Immunol; 2022; 13():900119. PubMed ID: 35812375
[TBL] [Abstract] [Full Text] [Related]
[Next]
